ESA Subcommittee on Transfusion, Haemostasis and Thrombosis
Aamer Ahmed, Christia Boer, Christian Fenger-Eriksen, and Christian von Heymann
Management of the bleeding or hypovolaemic patient has been a topic of increasing interest and been subject to major improvements in recent years. Point of care monitoring, targeted treatment, increasing availability of coagulation factor concentrates, and increased knowledge of the mechanism underlying coagulopathy represent key aspects of how we nowadays treat patients with severe bleeding. The approval of several direct oral anticoagulants, however, represents another challenge to the anaesthesiologist and intensive care physician as specific knowledge is necessary to guide these patients through the perioperative phase and to treat anticoagulant-associated bleeding. Further, a number of clinical challenges exist when dealing with a bleeding or potential bleeding patient: What kind of intravenous fluid to choose, when is it safe to insert spinal/epidurals or regional anaesthesia in patients on anticoagulants, what is the best transfusion strategy, how do I implement patient blood management, when should venous thrombosis prophylactics therapy be initiated after massive bleeding?
The up-coming ESA Focus Meeting entitled “Volume therapy; Transfusion, Haemostasis and Thrombosis in the perioperative setting” will be held in Sofia, Bulgaria, on 9-10 November 2018. The meeting is organised in collaboration with the Bulgarian Society of Anaesthesiologists and the Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis (NATA).
During the two-day meeting, top speakers from many different countries will debate challenges that we face when taking care of the bleeding patient, and the patient with a high risk of thromboembolic complications requiring anticoagulant treatment. Many interesting topics and up-dated research results related to prevention, treatment of the bleeding patient, fluid therapy, thrombosis prophylactics, transfusion strategy, and much more will be presented. You will have the opportunity to discuss these with renowned experts in this field.
Furthermore, we will give an outline of the newest ESA guidelines on venous thromboembolism and the management of severe perioperative bleeding. The small-scale meeting will allow participants to discuss and to share experiences and clinical problems with key opinion leaders during the plenary sessions and case presentations.
Challenging topics during the ESA Focus meeting are, amongst others, the role of point-of-care coagulation devices in patient blood management algorithms, the role of fibrinogen and other factor concentrates, best practices in the management of bleeding following a trauma patient, liver surgery, or postpartum haemorrhage, and the prevention of postoperative thromboembolic events.
During “How To” sessions you will be able to discover new approaches in the management of the patient who is taking anticoagulants, who is hypovolaemic or bleeding.
Why should one attend? One can be reassured that this ESA Focus meeting has all the necessary ingredients to be a rewarding experience. There is a realistic expectation of current opinions, research updates, new treatment concepts, constructive stimulating interactions, and active exchanges between delegates and speakers. Besides, this is a great opportunity to meet and create a new network with delegates from many different countries interested in bleeding and haemostasis management, coagulation monitoring, fluid therapy, transfusion strategies, and anticoagulation treatment.
We would like to warmly invite anaesthesiologists from all over Europe and farther afield to attend.